Hodgkin lymphoma and non-Hodgkin lymphoma are common malignancies in children and
are now highly treatable. Imaging plays a major role in diagnosis, staging and response …

Based on the advantages of revealing the functional status and molecular expression of
tumor cells, positron emission tomography (PET) imaging has been performed in numerous …

This phase 2 trial evaluated PET-adapted nivolumab alone or in combination with
ifosfamide, carboplatin, and etoposide (NICE) as first salvage therapy and bridge to …

Purpose Identifying patients at high risk of progression and early death among those with
high-tumor-burden follicular lymphoma (FL) is unsatisfactory with current prognostic models …

Purpose Lymphoma lesion detection and segmentation on whole-body FDG-PET/CT are a
challenging task because of the diversity of involved nodes, organs or physiological …

We tested baseline positron emission tomography (PET)/computed tomography (CT) as a
measure of total tumor burden to better identify high-risk patients with early-stage Hodgkin …

Patients with advanced-stage Hodgkin lymphoma (HL) demonstrated excellent 2-year
progression-free survival (PFS) after receiving positron emission tomography (PET) …

Purpose: The prognostic impact of total metabolic tumor volume (TMTV) measured on
pretreatment 18F-FDG PET/CT and its added value to molecular characteristics was …

Total metabolic tumor volume (TMTV), calculated from 18F-FDG PET/CT baseline studies, is
a prognostic factor in diffuse large B-cell lymphoma (DLBCL) whose measurement requires …

PURPOSE The prognosis of patients with early-stage unfavorable Hodgkin lymphoma
remains unsatisfactory. We assessed the efficacy and safety of brentuximab vedotin plus …